120 results
Page 5 of 6
6-K
65pavui4rmfr cjjh7t5
15 Jan 20
Current report (foreign)
8:35pm
6-K
EX-99.1
3lx oybsa
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.3
eb8u7ir6 95pa1juj
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.2
uwxcojdx97hv1oqop5
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.1
ukwlbswv6eg0te
31 Oct 19
ObsEva Announces Clearance to Initiate Pivotal US Phase 3 Clinical
4:21pm
6-K
EX-99.1
s5qvs y3txuvr53v
12 Sep 19
ObsEva announces new composition of its Executive Committee
8:16am
6-K
EX-99.1
z6ge0j4in
6 Sep 19
ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of
8:27am
F-3
EX-4.2
6iy724okocf0seba
7 Aug 19
Shelf registration (foreign)
8:24am
6-K
EX-99.1
tla2s6 11
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.3
zkmxgvmz 3l
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
n2npyl8gadxg
5 Jul 19
Current report (foreign)
6:01pm
6-K
qanqne
19 Jun 19
Current report (foreign)
4:30pm
6-K
EX-99.3
a83mdx99uoyov9a
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
jxvx0 0c2887q5mcmm
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
kd0n1
9 Oct 18
Current report (foreign)
4:42pm
6-K
flgbjg eoogwb9nma
3 Oct 18
Current report (foreign)
9:07am
6-K
yyw6oup15 urotagc2
28 Sep 18
Current report (foreign)
8:40am